Fred De Sauvage

Title: Fred De Sauvage: Innovator in Cancer Treatment

Introduction

Fred De Sauvage is a prominent inventor based in Foster City, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, De Sauvage has focused on developing methods that enhance the efficacy of cancer therapies while minimizing toxicity.

Latest Patents

One of his latest patents is centered on Notch pathway inhibition. This invention provides a method for inhibiting the Notch pathway with reduced toxicity, which is crucial for improving patient outcomes. Another significant patent involves compositions and methods for the treatment of cancer. This invention specifically addresses disorders characterized by the overexpression of an LIV-1. The compositions include DNA and amino acid sequences of an LIV-1, antibodies to an LIV-1, and methods for treating mammals diagnosed with cancer where an LIV-1 is overexpressed.

Career Highlights

Throughout his career, Fred De Sauvage has worked with notable organizations such as Genentech, Inc. and the University of California. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer treatment.

Collaborations

Some of his notable coworkers include Audrey Goddard and Austin L Gurney. Their collaborative efforts have further advanced the research and development of innovative cancer therapies.

Conclusion

Fred De Sauvage's contributions to cancer treatment through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact the lives of many patients facing cancer.